ltx-608
Generic: nafamostat
ltx-608: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| TALPHERA, INC. (TLPH) | Preclinical |
Get deeper analysis on ltx-608
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis